Physician profile
Kaci Oetjen
NPI 1194393918
$2,175.74
in general payments reported to CMS, 2019-2025
26 companies · $986 in 2025
The $986 reported for 2025 was more than what 89% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $274 · 2024: $779 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,002 · Travel and Lodging: $36.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,001.61 |
| Travel and Lodging | $36.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $395.74 | 2024-2025 | Endurant Iis |
| Boston Scientific Corporation | $378.30 | 2022-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Organogenesis INC. | $278.60 | 2024-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Janssen Pharmaceuticals, INC | $247.87 | 2024 | Xarelto |
| Convatec INC. | $120.02 | 2023-2025 | |
| Kerecis Limited | $110.12 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Silk Road Medical, INC. | $58.88 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Endologix LLC | $58.43 | 2023-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Solventum Corporation | $56.10 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Pfizer INC. | $48.02 | 2022-2023 | |
| Lemaitre Vascular, INC. | $46.26 | 2024-2025 | Artegraft Vascular Graft |
| Novo Nordisk INC | $44.67 | 2025 | Wegovy |
| Atricure, INC. | $43.30 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Cvrx, INC. | $43.29 | 2022 | |
| Inari Medical, INC. | $37.25 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $35.81 | 2023-2024 | Grafix, Stravix, Grafix Pl |
| E.R. Squibb & Sons, L.L.C. | $28.25 | 2022-2023 | |
| Tactile Systems Technology INC | $23.87 | 2022 | |
| My01 INC. | $22.45 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Inspiremd LTD | $18.52 | 2025 | Cguard Prime Carotid Stent System |
| Cashflow Solutions, LLC | $17.12 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| W. L. Gore & Associates, INC. | $17.09 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Baxter Healthcare | $14.71 | 2023 | Floseal |
| Veryan Medical Incorporated | $13.81 | 2022 | |
| Molnlycke Health Care US, LLC | $11.87 | 2025 | Tubigrip, Exufiber, Mepilex Transfer Ag |
| Ets Wound Care LLC | $5.39 | 2025 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaci Oetjen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.